| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Touchstone Center for Diabetes Research, University of Texas Southwestern Medical Center and Veterans Affairs Medical Center, Dallas, Texas 75390
Address all correspondence and requests for reprints to: Roger H. Unger, M.D., Touchstone Center for Diabetes Research, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Y8.212, Dallas, Texas 75390-8854. E-mail: roger.unger{at}utsouthwestern.edu.
The obesity crisis in the United States has been associated with an alarming increase in the prevalence of the metabolic syndrome (MSX) disease cluster. Here we review evidence that the MSX reflects a failure of a system of intracellular lipid homeostasis that prevents lipotoxicity in the organs of overnourished individuals by confining the lipid overload to cells specifically designed to store large quantities of surplus calories, the white adipocytes. Normally, early in obesity, adipocytes increase leptin and adiponectin secretion, hormones that enhance oxidation of surplus liquids in nonadipose tissues by activating AMP-activated protein kinase and reducing the activity and expression of lipogenic enzymes. These events combine to lower malonyl coenzyme A. Deficiency of and/or unresponsiveness to leptin prevents these protective events and results in ectopic accumulation of lipids. Increased de novo ceramide formation is probably the most damaging lipid and is a cause of lipoapoptosis, abetted by a decline in tissue Bcl-2. Pancreatic ß-cells and myocardiocytes are cellular victims of the process, leading to non-insulin-dependent diabetes and lipotoxic cardiomyopathy. The MSX is particularly prevalent in visceral obesity, probably because visceral adipocytes make less leptin than sc adipocytes. Cushings syndrome, the lipodystrophy associated with protease inhibitor therapy of AIDS, polycystic ovarian disease, as well as diet-induced visceral obesity, all have a high waist/hip ratio, and all exhibit MSX. Increased lipid content in the heart and skeletal muscle organs of such patients is now under study.
This article has been cited by other articles:
![]() |
K. Kantartzis, A. Peter, F. Machicao, J. Machann, S. Wagner, I. Konigsrainer, A. Konigsrainer, F. Schick, A. Fritsche, H.-U. Haring, et al. Dissociation Between Fatty Liver and Insulin Resistance in Humans Carrying a Variant of the Patatin-Like Phospholipase 3 Gene Diabetes, November 1, 2009; 58(11): 2616 - 2623. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Kienesberger, D. Lee, T. Pulinilkunnil, D. S. Brenner, L. Cai, C. Magnes, H. C. Koefeler, I. E. Streith, G. N. Rechberger, G. Haemmerle, et al. Adipose Triglyceride Lipase Deficiency Causes Tissue-specific Changes in Insulin Signaling J. Biol. Chem., October 30, 2009; 284(44): 30218 - 30229. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hu, J. Bielawski, F. Samad, A. H. Merrill Jr., and L. A. Cowart Palmitate increases sphingosine-1-phosphate in C2C12 myotubes via upregulation of sphingosine kinase message and activity J. Lipid Res., September 1, 2009; 50(9): 1852 - 1862. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shimamura, H. Takahashi, H. Kitazawa, Y. Miyamoto, A. Nagumo, C. Tang, D. Dean, T. Nagase, N. Sato, and S. Tokita Identification and Characterization of a Selective Radioligand for ELOVL6 J. Biochem., September 1, 2009; 146(3): 429 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Xu, M.-J. Dubois, N. Leung, A. Charbonneau, C. Turbide, R. K. Avramoglu, L. DeMarte, M. Elchebly, T. Streichert, E. Levy, et al. Targeted Disruption of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Promotes Diet-Induced Hepatic Steatosis and Insulin Resistance Endocrinology, August 1, 2009; 150(8): 3503 - 3512. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shimamura, H. Kitazawa, Y. Miyamoto, M. Kanesaka, A. Nagumo, R. Yoshimoto, K. Aragane, N. Morita, T. Ohe, T. Takahashi, et al. 5,5-Dimethyl-3-(5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-phenyl-3-(trifluoromethyl)-3,5,6,7-tetrahydro-1H-indole-2,4-dione, a Potent Inhibitor for Mammalian Elongase of Long-Chain Fatty Acids Family 6: Examination of Its Potential Utility as a Pharmacological Tool J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 249 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Despres Targeting abdominal obesity and the metabolic syndrome to manage cardiovascular disease risk Heart, July 1, 2009; 95(13): 1118 - 1124. [Full Text] [PDF] |
||||
![]() |
G. Yang, L. Badeanlou, J. Bielawski, A. J. Roberts, Y. A. Hannun, and F. Samad Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome Am J Physiol Endocrinol Metab, July 1, 2009; 297(1): E211 - E224. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. K. Luu, J. E. Pessin, S. Judex, J. Rubin, and C. T. Rubin Mechanical Signals As a Non-Invasive Means to Influence Mesenchymal Stem Cell Fate, Promoting Bone and Suppressing the Fat Phenotype IBMS BoneKEy, April 1, 2009; 6(4): 132 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Holloway, C. R. Benton, K. L. Mullen, Y. Yoshida, L. A. Snook, X.-X. Han, J. F. C. Glatz, J. J. F. P. Luiken, J. Lally, D. J. Dyck, et al. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E738 - E747. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Turpin, J. G. Ryall, R. Southgate, I. Darby, A. L. Hevener, M. A. Febbraio, B. E. Kemp, G. S. Lynch, and M. J. Watt Examination of 'lipotoxicity' in skeletal muscle of high-fat fed and ob/ob mice J. Physiol., April 1, 2009; 587(7): 1593 - 1605. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Despres, R. Ross, G. Boka, N. Almeras, I. Lemieux, and for the ADAGIO-Lipids Investigators Effect of Rimonabant on the High-Triglyceride/ Low-HDL-Cholesterol Dyslipidemia, Intraabdominal Adiposity, and Liver Fat: The ADAGIO-Lipids Trial Arterioscler Thromb Vasc Biol, March 1, 2009; 29(3): 416 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Johnson, S. E. Perez-Pozo, Y. Y. Sautin, J. Manitius, L. G. Sanchez-Lozada, D. I. Feig, M. Shafiu, M. Segal, R. J. Glassock, M. Shimada, et al. Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes? Endocr. Rev., February 1, 2009; 30(1): 96 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Haus, S. R. Kashyap, T. Kasumov, R. Zhang, K. R. Kelly, R. A. DeFronzo, and J. P. Kirwan Plasma Ceramides Are Elevated in Obese Subjects With Type 2 Diabetes and Correlate With the Severity of Insulin Resistance Diabetes, February 1, 2009; 58(2): 337 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Mullen, J. Pritchard, I. Ritchie, L. A. Snook, A. Chabowski, A. Bonen, D. Wright, and D. J. Dyck Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2009; 296(2): R243 - R251. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. P. Flint, M. A. Noor, P. W. Hruz, P. B. Hylemon, K. Yarasheski, D. P. Kotler, R. A. Parker, and A. Bellamine The Role of Protease Inhibitors in the Pathogenesis of HIV-Associated Lipodystrophy: Cellular Mechanisms and Clinical Implications Toxicol Pathol, January 1, 2009; 37(1): 65 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bonzon-Kulichenko, D. Schwudke, N. Gallardo, E. Molto, T. Fernandez-Agullo, A. Shevchenko, and A. Andres Central Leptin Regulates Total Ceramide Content and Sterol Regulatory Element Binding Protein-1C Proteolytic Maturation in Rat White Adipose Tissue Endocrinology, January 1, 2009; 150(1): 169 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Stefan, K. Kantartzis, and H.-U. Haring Causes and Metabolic Consequences of Fatty Liver Endocr. Rev., December 1, 2008; 29(7): 939 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Shi, A. Burkart, S. M. Nicoloro, M. P. Czech, J. Straubhaar, and S. Corvera Paradoxical Effect of Mitochondrial Respiratory Chain Impairment on Insulin Signaling and Glucose Transport in Adipose Cells J. Biol. Chem., November 7, 2008; 283(45): 30658 - 30667. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Glick Pathogenesis as the Basis for Disease Prevention: A Worthwhile Pursuit J Am Dent Assoc, October 1, 2008; 139(10): 1300 - 1302. [Full Text] [PDF] |
||||
![]() |
S. Satapati, T. He, T. Inagaki, M. Potthoff, M. E. Merritt, V. Esser, D. J. Mangelsdorf, S. A. Kliewer, J. D. Browning, and S. C. Burgess Partial Resistance to Peroxisome Proliferator-Activated Receptor-{alpha} Agonists in ZDF Rats Is Associated With Defective Hepatic Mitochondrial Metabolism Diabetes, August 1, 2008; 57(8): 2012 - 2021. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Harmancey, C. R. Wilson, and H. Taegtmeyer Adaptation and Maladaptation of the Heart in Obesity Hypertension, August 1, 2008; 52(2): 181 - 187. [Full Text] [PDF] |
||||
![]() |
J. B. Schwimmer, P. E. Pardee, J. E. Lavine, A. K. Blumkin, and S. Cook Cardiovascular Risk Factors and the Metabolic Syndrome in Pediatric Nonalcoholic Fatty Liver Disease Circulation, July 15, 2008; 118(3): 277 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Puri, S. Ranjit, S. Konda, S. M. C. Nicoloro, J. Straubhaar, A. Chawla, M. Chouinard, C. Lin, A. Burkart, S. Corvera, et al. Cidea is associated with lipid droplets and insulin sensitivity in humans PNAS, June 3, 2008; 105(22): 7833 - 7838. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Couchepin, K.-A. Le, M. Bortolotti, J. A. da Encarnacao, J.-B. Oboni, C. Tran, P. Schneiter, and L. Tappy Markedly Blunted Metabolic Effects of Fructose in Healthy Young Female Subjects Compared With Male Subjects Diabetes Care, June 1, 2008; 31(6): 1254 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Holloway, C. G. R. Perry, A. B. Thrush, G. J. F. Heigenhauser, D. J. Dyck, A. Bonen, and L. L. Spriet PGC-1{alpha}'s relationship with skeletal muscle palmitate oxidation is not present with obesity despite maintained PGC-1{alpha} and PGC-1{beta} protein Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1060 - E1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Poitout and R. P. Robertson Glucolipotoxicity: Fuel Excess and {beta}-Cell Dysfunction Endocr. Rev., May 1, 2008; 29(3): 351 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Merino, V. Cano, R. Guzman, B. Somoza, and M. Ruiz-Gayo Leptin-Mediated Hypothalamic Pathway of Cholecystokinin (CCK-8) to Regulate Body Weight in Free-Feeding Rats Endocrinology, April 1, 2008; 149(4): 1994 - 2000. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Unger Reinventing Type 2 Diabetes: Pathogenesis, Treatment, and Prevention JAMA, March 12, 2008; 299(10): 1185 - 1187. [Full Text] [PDF] |
||||
![]() |
F. F. Chehab Minireview: Obesity and LipOdystrophy--Where Do the Circles Intersect? Endocrinology, March 1, 2008; 149(3): 925 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Hagman, M. G. Latour, S. K. Chakrabarti, G. Fontes, J. Amyot, C. Tremblay, M. Semache, J. A. Lausier, V. Roskens, R. G. Mirmira, et al. Cyclical and Alternating Infusions of Glucose and Intralipid in Rats Inhibit Insulin Gene Expression and Pdx-1 Binding in Islets Diabetes, February 1, 2008; 57(2): 424 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Hofmann, D. Perez-Tilve, T. M. Greer, B. A. Coburn, E. Grant, J. E. Basford, M. H. Tschop, and D. Y. Hui Defective Lipid Delivery Modulates Glucose Tolerance and Metabolic Response to Diet in Apolipoprotein E Deficient Mice Diabetes, January 1, 2008; 57(1): 5 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gallardo, E. Bonzon-Kulichenko, T. Fernandez-Agullo, E. Molto, S. Gomez-Alonso, P. Blanco, J. M. Carrascosa, M. Ros, and A. Andres Tissue-Specific Effects of Central Leptin on the Expression of Genes Involved in Lipid Metabolism in Liver and White Adipose Tissue Endocrinology, December 1, 2007; 148(12): 5604 - 5610. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Nelson, R. Basu, C. M. Johnson, R. A. Rizza, and J. M. Miles Splanchnic Spillover of Extracellular Lipase Generated Fatty Acids in Overweight and Obese Humans Diabetes, December 1, 2007; 56(12): 2878 - 2884. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Levin, M. Monetti, M. J. Watt, M. P. Sajan, R. D. Stevens, J. R. Bain, C. B. Newgard, R. V. Farese Sr., and R. V. Farese Jr. Increased lipid accumulation and insulin resistance in transgenic mice expressing DGAT2 in glycolytic (type II) muscle Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1772 - E1781. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Rubin, E. Capilla, Y. K. Luu, B. Busa, H. Crawford, D. J. Nolan, V. Mittal, C. J. Rosen, J. E. Pessin, and S. Judex Adipogenesis is inhibited by brief, daily exposure to high-frequency, extremely low-magnitude mechanical signals PNAS, November 6, 2007; 104(45): 17879 - 17884. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Schwartz and N. E. Wolins A simple and rapid method to assay triacylglycerol in cells and tissues J. Lipid Res., November 1, 2007; 48(11): 2514 - 2520. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Aslanidi, V. Kroutov, G. Philipsberg, K. Lamb, M. Campbell-Thompson, G. A. Walter, S. Kurenov, J. Ignacio Aguirre, P. Keller, K. Hankenson, et al. Ectopic expression of Wnt10b decreases adiposity and improves glucose homeostasis in obese rats Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E726 - E736. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Muller, N. Schweitzer, O. Johren, P. Dominiak, and W. Raasch Angiotensin II stimulates the reactivity of the pituitary-adrenal axis in leptin-resistant Zucker rats, thereby influencing the glucose utilization Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E802 - E810. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Malhi, F. J Barreyro, H. Isomoto, S. F Bronk, and G. J Gores Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity Gut, August 1, 2007; 56(8): 1124 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, M. M. Masternak, K. A. Al-Regaiey, and A. Bartke Adipocytokines and the Regulation of Lipid Metabolism in Growth Hormone Transgenic and Calorie-Restricted Mice Endocrinology, June 1, 2007; 148(6): 2845 - 2853. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhao, M. Przybylska, I-H. Wu, J. Zhang, C. Siegel, S. Komarnitsky, N. S. Yew, and S. H. Cheng Inhibiting Glycosphingolipid Synthesis Improves Glycemic Control and Insulin Sensitivity in Animal Models of Type 2 Diabetes Diabetes, May 1, 2007; 56(5): 1210 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Wahba and R. H. Mak Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Links to Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 550 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Aerts, R. Ottenhoff, A. S. Powlson, A. Grefhorst, M. van Eijk, P. F. Dubbelhuis, J. Aten, F. Kuipers, M. J. Serlie, T. Wennekes, et al. Pharmacological Inhibition of Glucosylceramide Synthase Enhances Insulin Sensitivity Diabetes, May 1, 2007; 56(5): 1341 - 1349. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Savage, K. F. Petersen, and G. I. Shulman Disordered Lipid Metabolism and the Pathogenesis of Insulin Resistance Physiol Rev, April 1, 2007; 87(2): 507 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Tschop, D. Y. Hui, and T. L. Horvath Diet-Induced Leptin Resistance: The Heart of the Matter Endocrinology, March 1, 2007; 148(3): 921 - 923. [Full Text] [PDF] |
||||
![]() |
B. Somoza, R. Guzman, V. Cano, B. Merino, P. Ramos, C. Diez-Fernandez, M. S. Fernandez-Alfonso, and M. Ruiz-Gayo Induction of Cardiac Uncoupling Protein-2 Expression and Adenosine 5'-Monophosphate-Activated Protein Kinase Phosphorylation during Early States of Diet-Induced Obesity in Mice Endocrinology, March 1, 2007; 148(3): 924 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Nelson, A. Prasad, A. Lerman, and J. M. Miles Myocardial Uptake of Circulating Triglycerides in Nondiabetic Patients With Heart Disease Diabetes, February 1, 2007; 56(2): 527 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Turpin, G. I. Lancaster, I. Darby, M. A. Febbraio, and M. J. Watt Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1341 - E1350. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Thakker, N. G. Frangogiannis, M. Bujak, P. Zymek, J. W. Gaubatz, A. K. Reddy, G. Taffet, L. H. Michael, M. L. Entman, and C. M. Ballantyne Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2504 - H2514. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Kim, K. Tillison, J.-H. Lee, D. A. Rearick, and C. M. Smas The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-{alpha} in 3T3-L1 adipocytes and is a target for transactivation by PPAR{gamma} Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E115 - E127. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. McGavock, R. G. Victor, R. H. Unger, and L. S. Szczepaniak Adiposity of the Heart*, Revisited Ann Intern Med, April 4, 2006; 144(7): 517 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Suviolahti, K. Reue, R. M. Cantor, J. Phan, M. Gentile, J. Naukkarinen, A. Soro-Paavonen, L. Oksanen, J. Kaprio, A. Rissanen, et al. Cross-species analyses implicate Lipin 1 involvement in human glucose metabolism Hum. Mol. Genet., February 1, 2006; 15(3): 377 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wang, Y. Wei, and M. J. Pagliassotti Saturated Fatty Acids Promote Endoplasmic Reticulum Stress and Liver Injury in Rats with Hepatic Steatosis Endocrinology, February 1, 2006; 147(2): 943 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Barouch, D. Gao, L. Chen, K. L. Miller, W. Xu, A. C. Phan, M. M. Kittleson, K. M. Minhas, D. E. Berkowitz, C. Wei, et al. Cardiac Myocyte Apoptosis Is Associated With Increased DNA Damage and Decreased Survival in Murine Models of Obesity Circ. Res., January 6, 2006; 98(1): 119 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Kahn The Lipid Accumulation Product Is Better Than BMI for Identifying Diabetes: A population-based comparison Diabetes Care, January 1, 2006; 29(1): 151 - 153. [Full Text] [PDF] |
||||
![]() |
M. Hamaguchi, T. Kojima, N. Takeda, T. Nakagawa, H. Taniguchi, K. Fujii, T. Omatsu, T. Nakajima, H. Sarui, M. Shimazaki, et al. The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease Ann Intern Med, November 15, 2005; 143(10): 722 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Hagman, L. B. Hays, S. D. Parazzoli, and V. Poitout{paragraph} Palmitate Inhibits Insulin Gene Expression by Altering PDX-1 Nuclear Localization and Reducing MafA Expression in Isolated Rat Islets of Langerhans J. Biol. Chem., September 16, 2005; 280(37): 32413 - 32418. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bostrom, M. Rutberg, J. Ericsson, P. Holmdahl, L. Andersson, M. A. Frohman, J. Boren, and S.-O. Olofsson Cytosolic Lipid Droplets Increase in Size by Microtubule-Dependent Complex Formation Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1945 - 1951. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tanaka, S. Hidaka, H. Masuzaki, S. Yasue, Y. Minokoshi, K. Ebihara, H. Chusho, Y. Ogawa, T. Toyoda, K. Sato, et al. Skeletal Muscle AMP-Activated Protein Kinase Phosphorylation Parallels Metabolic Phenotype in Leptin Transgenic Mice Under Dietary Modification Diabetes, August 1, 2005; 54(8): 2365 - 2374. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Stanley, F. A. Recchia, and G. D. Lopaschuk Myocardial Substrate Metabolism in the Normal and Failing Heart Physiol Rev, July 1, 2005; 85(3): 1093 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Park, H. K. Rho, K. H. Kim, S. S. Choe, Y. S. Lee, and J. B. Kim Overexpression of Glucose-6-Phosphate Dehydrogenase Is Associated with Lipid Dysregulation and Insulin Resistance in Obesity Mol. Cell. Biol., June 15, 2005; 25(12): 5146 - 5157. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. T. Bloomgarden Second World Congress on the Insulin Resistance Syndrome: Insulin resistance syndrome and nonalcoholic fatty liver disease Diabetes Care, June 1, 2005; 28(6): 1518 - 1523. [Full Text] [PDF] |
||||
![]() |
Y.-H. Yu and H. N. Ginsberg Adipocyte Signaling and Lipid Homeostasis: Sequelae of Insulin-Resistant Adipose Tissue Circ. Res., May 27, 2005; 96(10): 1042 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Wolins, B. K. Quaynor, J. R. Skinner, M. J. Schoenfish, A. Tzekov, and P. E. Bickel S3-12, Adipophilin, and TIP47 Package Lipid in Adipocytes J. Biol. Chem., May 13, 2005; 280(19): 19146 - 19155. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Qi, J. Wang, V. Zidek, V. Landa, P. Mlejnek, L. Kazdova, M. Pravenec, and T. W. Kurtz A New Transgenic Rat Model of Hepatic Steatosis and the Metabolic Syndrome Hypertension, May 1, 2005; 45(5): 1004 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Vertino, J. M. Taylor-Jones, K. A. Longo, E. D. Bearden, T. F. Lane, R. E. McGehee Jr., O. A. MacDougald, and C. A. Peterson Wnt10b Deficiency Promotes Coexpression of Myogenic and Adipogenic Programs in Myoblasts Mol. Biol. Cell, April 1, 2005; 16(4): 2039 - 2048. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Summers and D. H. Nelson A Role for Sphingolipids in Producing the Common Features of Type 2 Diabetes, Metabolic Syndrome X, and Cushing's Syndrome Diabetes, March 1, 2005; 54(3): 591 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W.K. Ng, G. F. Watts, M. S. Farvid, D. C. Chan, and P. H. R. Barrett Adipocytokines and VLDL Metabolism: Independent Regulatory Effects of Adiponectin, Insulin Resistance, and Fat Compartments on VLDL Apolipoprotein B-100 Kinetics? Diabetes, March 1, 2005; 54(3): 795 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Savage, P. R. Murgatroyd, V. K. Chatterjee, and S. O'Rahilly Energy Expenditure and Adaptive Responses to an Acute Hypercaloric Fat Load in Humans with Lipodystrophy J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1446 - 1452. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Chan, G. F. Watts, T. W.K. Ng, Y. Uchida, N. Sakai, S. Yamashita, and P. H. R. Barrett Adiponectin and other Adipocytokines as Predictors of Markers of Triglyceride-Rich Lipoprotein Metabolism Clin. Chem., March 1, 2005; 51(3): 578 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cruciani-Guglielmacci, M. Vincent-Lamon, C. Rouch, M. Orosco, A. Ktorza, and C. Magnan Early changes in insulin secretion and action induced by high-fat diet are related to a decreased sympathetic tone Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E148 - E154. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Tulipano, A V Vergoni, D Soldi, E E Muller, and D Cocchi Characterization of the resistance to the anorectic and endocrine effects of leptin in obesity-prone and obesity-resistant rats fed a high-fat diet J. Endocrinol., November 1, 2004; 183(2): 289 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Bagby Obesity-Initiated Metabolic Syndrome and the Kidney: A Recipe for Chronic Kidney Disease? J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2775 - 2791. [Full Text] [PDF] |
||||
![]() |
C. Bouche, S. Serdy, C. R. Kahn, and A. B. Goldfine The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes Endocr. Rev., October 1, 2004; 25(5): 807 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J.G. Hanley, K. Williams, A. Festa, L. E. Wagenknecht, R. B. D'Agostino Jr., J. Kempf, B. Zinman, and S. M. Haffner Elevations in Markers of Liver Injury and Risk of Type 2 Diabetes: The Insulin Resistance Atherosclerosis Study Diabetes, October 1, 2004; 53(10): 2623 - 2632. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Poitout {beta}-Cell Lipotoxicity: Burning Fat into Heat? Endocrinology, August 1, 2004; 145(8): 3563 - 3565. [Full Text] [PDF] |
||||
![]() |
F. Vinicor and B. Bowman The Metabolic Syndrome: The Emperor Needs Some Consistent Clothes: Response to Davidson and Alexander Diabetes Care, May 1, 2004; 27(5): 1243 - 1243. [Full Text] [PDF] |
||||
![]() |
N. B. Ruderman, A. K. Saha, and E. W. Kraegen Minireview: Malonyl CoA, AMP-Activated Protein Kinase, and Adiposity Endocrinology, December 1, 2003; 144(12): 5166 - 5171. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |